Consolidated Portfolio Review Corp’s Barings Corporate Investors MCI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-10,217
Closed -$221K 478
2025
Q2
$221K Hold
10,217
0.03% 412
2025
Q1
$239K Buy
10,217
+115
+1% +$2.42K 0.04% 333
2024
Q4
$206K Buy
+10,102
New +$200K 0.03% 352
2023
Q4
Sell
-10,751
Closed -$171K 315
2023
Q3
$171K Buy
10,751
+166
+2% +$2.54K 0.04% 303
2023
Q2
$158K Buy
10,585
+155
+1% +$2.19K 0.04% 303
2023
Q1
$148K Buy
+10,430
New +$148K 0.04% 269

Other funds holding MCI

Consolidated Portfolio Review Corp's MCI Position: Q3 2025 in Review

Consolidated Portfolio Review Corp sold out of Barings Corporate Investors (MCI) in Q3 2025, closing a stake of 10,217 shares — an estimated $221K sold.

Consolidated Portfolio Review Corp first reported a position in MCI in Q1 2023 and held it in 6 quarters. The position peaked at $239K in Q1 2025. 66 funds tracked by Wall St. Rank hold MCI as of Q3 2025.

  • Consolidated Portfolio Review Corp reported no remaining Barings Corporate Investors position as of Q3 2025 after selling out during the quarter.
  • Consolidated Portfolio Review Corp sold 10,217 Barings Corporate Investors shares in Q3 2025, an estimated $221K.
  • Consolidated Portfolio Review Corp first reported a position in Barings Corporate Investors in Q1 2023 and held it in 6 quarters.
  • Consolidated Portfolio Review Corp's Barings Corporate Investors position peaked at $239K in Q1 2025.
  • 66 funds tracked by Wall St. Rank held Barings Corporate Investors as of Q3 2025.

Based on Consolidated Portfolio Review Corp's 13F filing for Q3 2025, filed 12 Nov 2025.